NTI drug but with high CV [Power / Sample Size]

posted by Mikalai  – Belarus, 2019-12-14 16:39 (1086 d 22:50 ago) – Posting: # 20975
Views: 2,649

Dear all.
What would be a sample size for a BE study when the CV of the drug is 30% but bioequivalence should be in range 90_110%? Our assumption is around 400 subject if the design is standard, and 200 if the design is replicative
Best regards.

Complete thread:

UA Flag
Activity
 Admin contact
22,428 posts in 4,694 threads, 1,598 registered users;
21 visitors (0 registered, 21 guests [including 10 identified bots]).
Forum time: 15:29 CET (Europe/Vienna)

Statistics is the art of never having to say you’re wrong.
Variance is what any two statisticians are at.    C.J. Bradfield

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5